|
|
|
|
| LEADER |
00000cam a22000002 4500 |
| 001 |
1840041625 |
| 003 |
DE-627 |
| 005 |
20230325055011.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
230324s2018 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.3886/ICPSR36043.v1
|2 doi
|
| 035 |
|
|
|a (DE-627)1840041625
|
| 035 |
|
|
|a (DE-599)KXP1840041625
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 084 |
|
|
|a 2,1
|2 ssgn
|
| 100 |
1 |
|
|a Freeman, Patricia
|e VerfasserIn
|4 aut
|
| 245 |
1 |
0 |
|a Optimizing Prescription Drug Monitoring Programs to Support Law Enforcement Activities, United States, 2013-2014
|
| 264 |
|
1 |
|a [Erscheinungsort nicht ermittelbar]
|b [Verlag nicht ermittelbar]
|c 2018
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 520 |
|
|
|a These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed. The purpose of this study was to characterize Prescription Drug Monitoring Programs' (PDMP) features and practices that are optimal for supporting law enforcement investigations and prosecutions of prescription drug diversion cases. The study collection includes 1 CSV data file (OptimizingPDMPsToSup_DATA_NOHDRS_2015-01-29_1235.csv, n=1,834, 204 variables). The qualitative data is not available as part of this collection at this time.
|
| 540 |
|
|
|a ICPSR Terms of Use
|
| 650 |
|
4 |
|a controlled drugs
|
| 650 |
|
4 |
|a Drug Abuse
|
| 650 |
|
4 |
|a drug dispensing
|
| 650 |
|
4 |
|a drug law enforcement
|
| 650 |
|
4 |
|a Drug traffic
|
| 650 |
|
4 |
|a Law Enforcement
|
| 650 |
|
4 |
|a law enforcement agencies
|
| 650 |
|
4 |
|a Police
|
| 650 |
|
4 |
|a Prescription Drugs
|
| 650 |
|
4 |
|a Public Health
|
| 655 |
|
7 |
|a Forschungsdaten
|0 (DE-588)1098579690
|0 (DE-627)857755366
|0 (DE-576)469182156
|2 gnd-content
|
| 700 |
1 |
|
|a Blumenschein, Karen
|e MitwirkendeR
|4 ctb
|
| 856 |
4 |
0 |
|u https://doi.org/10.3886/ICPSR36043.v1
|x Resolving-System
|z kostenfrei
|3 Volltext
|
| 935 |
|
|
|a mkri
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|a 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 4296788892
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1840041625
|
| LOK |
|
|
|0 005 20230324125133
|
| LOK |
|
|
|0 008 230324||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 035
|a (DE-2619)ICPSR36043
|
| LOK |
|
|
|0 040
|a DE-2619
|c DE-627
|d DE-2619
|
| LOK |
|
|
|0 092
|o n
|
| LOK |
|
|
|0 852
|a DE-2619
|
| LOK |
|
|
|0 852 1
|9 00
|
| LOK |
|
|
|0 935
|a foda
|a nacj
|
| OAS |
|
|
|a 1
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
